The emetic profile of action of cisplatin 5 and 10 mg/kg i.p. was investigated in the ferret over a 72 and 24hr period respectively. The 5-HT3 receptor antagonists ondansetron and alosetron markedly antagonized or abolished the emesis during the ''acute phase'' and, whilst antagonizing the emesis during the delayed phase, also revealed a 5-HT3 receptor antagonist resistant component. These cisplatin paradigms may provide models relevant to the study of acute and delayed emesis induced by cisplatin in man.
引用
收藏
页码:1607 / 1608
页数:2
相关论文
共 5 条
[1]
ANDREWS PLR, 1993, EMESIS ANTICANCER TH, P113
[2]
BUTCHER ME, 1993, ONCOLOGY-BASEL, V50, P191
[3]
KILPATRICK G J, 1991, British Journal of Pharmacology, V104, p259P